Ken Griffin Nuvasive Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.71 - $44.15 $2.29 Million - $2.75 Million	-62,281 Reduced 85.62%	10,460 $435,000
Q1 2023 May 15, 2023	SELL	$36.81 - $48.12 $9.61 Million - $12.6 Million	-261,130 Reduced 78.21%	72,741 $3 Million
Q4 2022 Feb 14, 2023	SELL	$35.68 - $44.71 $57.5 Million - $72.1 Million	-1,612,402 Reduced 82.85%	333,871 $13.8 Million
Q3 2022 Nov 14, 2022	BUY	$42.51 - $54.02 $20.6 Million - $26.2 Million	485,561 Added 33.24%	1,946,273 $85.3 Million
Q2 2022 Aug 15, 2022	SELL	$46.84 - $59.75 $382,870 - $488,396	-8,174 Reduced 0.56%	1,460,712 $71.8 Million
Q1 2022 May 16, 2022	BUY	$48.09 - $57.79 $6.4 Million - $7.69 Million	133,068 Added 9.96%	1,468,886 $83.3 Million
Q4 2021 Feb 14, 2022	BUY	$47.19 - $62.68 $49 Million - $65.1 Million	1,038,724 Added 349.63%	1,335,818 $70.1 Million
Q3 2021 Nov 15, 2021	SELL	$56.91 - $67.81 $16.1 Million - $19.2 Million	-282,884 Reduced 48.77%	297,094 $17.8 Million
Q2 2021 Aug 16, 2021	BUY	$64.02 - $71.72 $17.7 Million - $19.8 Million	275,818 Added 90.68%	579,978 $39.3 Million
Q1 2021 May 17, 2021	SELL	$53.26 - $68.08 $50.5 Million - $64.5 Million	-947,981 Reduced 75.71%	304,160 $19.9 Million
Q4 2020 Feb 16, 2021	SELL	$43.41 - $56.51 $33.9 Million - $44.1 Million	-780,184 Reduced 38.39%	1,252,141 $70.5 Million
Q3 2020 Nov 16, 2020	BUY	$47.43 - $60.75 $14.7 Million - $18.8 Million	309,578 Added 17.97%	2,032,325 $98.7 Million
Q2 2020 Aug 14, 2020	BUY	$43.51 - $66.59 $20.3 Million - $31.1 Million	467,396 Added 37.23%	1,722,747 $95.9 Million
Q1 2020 May 15, 2020	BUY	$32.82 - $81.13 $8.71 Million - $21.5 Million	265,434 Added 26.81%	1,255,351 $63.6 Million
Q4 2019 Feb 14, 2020	BUY	$60.96 - $77.7 $28.3 Million - $36.1 Million	464,219 Added 88.31%	989,917 $76.6 Million
Q3 2019 Nov 14, 2019	BUY	$55.78 - $68.08 $23.7 Million - $28.9 Million	424,514 Added 419.55%	525,698 $33.3 Million
Q2 2019 Aug 14, 2019	SELL	$53.69 - $65.47 $5.6 Million - $6.83 Million	-104,334 Reduced 50.77%	101,184 $5.92 Million
Q1 2019 May 15, 2019	BUY	$44.53 - $58.9 $3.42 Million - $4.52 Million	76,758 Added 59.61%	205,518 $0
Q4 2018 Feb 14, 2019	BUY	$47.64 - $71.26 $5.83 Million - $8.71 Million	122,294 Added 1891.34%	128,760 $6.38 Million
Q3 2018 Nov 13, 2018	BUY	$52.03 - $71.41 $62,123 - $85,263	1,194 Added 22.65%	6,466 $0
Q2 2018 Aug 10, 2018	SELL	$48.15 - $56.68 $1.96 Million - $2.3 Million	-40,635 Reduced 88.52%	5,272 $0
Q1 2018 May 11, 2018	SELL	$46.03 - $61.28 $76.7 Million - $102 Million	-1,666,658 Reduced 97.32%	45,907 $2.4 Million
Q4 2017 Feb 09, 2018	BUY	$50.58 - $60.79 $37.5 Million - $45.1 Million	741,423 Added 76.35%	1,712,565 $100 Million
Q3 2017 Nov 09, 2017	BUY	$53.54 - $68.0 $52 Million - $66 Million	971,142	971,142 $53.9 Million

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account